DNA

Helping Families Navigate I/DD Services funded by Medicaid- 10,000 Users and Counting

PALATINE, Ill., Nov. 19, 2025 /PRNewswire/ -- The IDD Navigator platform, launched by Little City with funding from The Coleman Foundation,…

2 months ago

DeepView™ System Featured at 2025 US Burn Conferences

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

2 months ago

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show…

2 months ago

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…

2 months ago

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free…

2 months ago

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

IRVINE, Calif., Nov. 18, 2025 /PRNewswire/ -- Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic…

2 months ago

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.

– Partnership focuses on "kitted" tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially…

2 months ago

Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer

More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and…

2 months ago

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and EcuadorBERKELEY, Calif.…

2 months ago